4.8 Article

A photoswitchable GPCR-based opsin for presynaptic inhibition

Journal

NEURON
Volume 109, Issue 11, Pages 1791-+

Publisher

CELL PRESS
DOI: 10.1016/j.neuron.2021.04.026

Keywords

-

Categories

Funding

  1. NIH BRAIN Initiative [R01 MH111520]
  2. NIH [R21 DA049569, K01 DA042219, K01 DK115634, T32DA007278, R35 GM122577, P30DA048736]
  3. Mary Gates Research Fellowship
  4. Scan Design Research Foundation
  5. Hope Center Viral Vectors Core at Washington University School of Medicine

Ask authors/readers for more resources

This study introduces a GPCR-based opsin called parapinopsin (PPO), which can rapidly and reversibly inhibit the release of glutamate, GABA, and dopamine at presynaptic terminals by coupling with G(i/o) signaling cascades. PPO alters reward behaviors in a time-locked and reversible manner in vivo, filling a significant gap in the neuroscience toolkit for rapid and reversible synaptic inhibition.
Optical manipulations of genetically defined cell types have generated significant insights into the dynamics of neural circuits. While optogenetic activation has been relatively straightforward, rapid and reversible synaptic inhibition has proven more elusive. Here, we leveraged the natural ability of inhibitory presynaptic GPCRs to suppress synaptic transmission and characterize parapinopsin (PPO) as a GPCR-based opsin for terminal inhibition. PPO is a photoswitchable opsin that couples to G(i/o) signaling cascades and is rapidly activated by pulsed blue light, switched off with amber light, and effective for repeated, prolonged, and reversible inhibition. PPO rapidly and reversibly inhibits glutamate, GABA, and dopamine release at presynaptic terminals. Furthermore, PPO alters reward behaviors in a time-locked and reversible manner in vivo. These results demonstrate that PPO fills a significant gap in the neuroscience toolkit for rapid and reversible synaptic inhibition and has broad utility for spatiotemporal control of inhibitory GPCR signaling cascades.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Comments

Wai Lo
Scientists have developed a new way to genetically insert a type of light receptor into neurons. The new technique enables the researchers to suppress the neuron’s activity using pulses of light.

Recommended

Article Biochemistry & Molecular Biology

Dopamine release in the nucleus accumbens core signals perceived saliency

Munir Gunes Kutlu, Jennifer E. Zachry, Patrick R. Melugin, Stephanie A. Cajigas, Maxime F. Chevee, Shannon J. Kelly, Banu Kutlu, Lin Tian, Cody A. Siciliano, Erin S. Calipari

Summary: Research has shown that dopamine release patterns conform to different encoding mechanisms in different contexts, not solely determined by reward prediction error theory.

CURRENT BIOLOGY (2021)

Review Neurosciences

Letting the little light of mind shine: Advances and future directions in neurochemical detection

Nikki Tjahjono, Yihan Jin, Alice Hsu, Michael Roukes, Lin Tian

Summary: This article reviews the development of measurement methods for neurotransmitter release and discusses the advantages and challenges of each technology, providing a guide for tool engineering and applications in recording neurochemical release.

NEUROSCIENCE RESEARCH (2022)

Article Oncology

Integrative RNA-omics Discovers GNAS Alternative Splicing as a Phenotypic Driver of Splicing Factor-Mutant Neoplasms

Emily C. Wheeler, Shailee Vora, Daniel Mayer, Andriana G. Kotini, Malgorzata Olszewska, Samuel S. Park, Ernesto Guccione, Julie Teruya-Feldstein, Lewis Silverman, Roger K. Sunahara, Gene W. Yeo, Eirini P. Papapetrou

Summary: The study identified a long isoform of GNAS as a direct target of convergent missplicing by mutant U2AF1 and SRSF2, which activates G protein and ERK/MAPK signaling, driving MDS and rendering mutant cells sensitive to MEK inhibition. The findings suggest a potential therapeutic target for MDS and other SF-mutant neoplasms.

CANCER DISCOVERY (2022)

Review Neurosciences

Fluorescence Imaging of Neural Activity, Neurochemical Dynamics, and Drug-Specific Receptor Conformation with Genetically Encoded Sensors

Chunyang Dong, Yu Zheng, Kiran Long-Iyer, Emily C. Wright, Yulong Li, Lin Tian

Summary: Recent advances in fluorescence imaging have allowed us to record neural activity and neurochemical release with unprecedented resolution. Genetically encoded fluorescent indicators provide valuable insights into neural activity and neuromodulation.

ANNUAL REVIEW OF NEUROSCIENCE (2022)

Article Biology

Multimodal detection of dopamine by sniffer cells expressing genetically encoded fluorescent sensors

Carmen Klein Herenbrink, Jonatan Fullerton Stoier, William Dalseg Reith, Abeer Dagra, Miguel Alejandro Cuadrado Gregorek, Reto B. Cola, Tommaso Patriarchi, Yulong Li, Lin Tian, Ulrik Gether, Freja Herborg

Summary: This study develops dopamine sensor cell lines expressing fluorescent reporters, which can be used to detect endogenous dopamine release, determine dopamine tissue content, and measure dopamine uptake and efflux. This versatile tool has a wide range of applications.

COMMUNICATIONS BIOLOGY (2022)

Article Chemistry, Multidisciplinary

Wireless, Battery-Free Implants for Electrochemical Catecholamine Sensing and Optogenetic Stimulation

Tucker Stuart, William J. Jeang, Richard A. Slivicki, Bobbie J. Brown, Alex Burton, Victoria E. Brings, Lilian C. Alarcon-Segovia, Prophecy Agyare, Savanna Ruiz, Amanda Tyree, Lindsay Pruitt, Surabhi Madhvapathy, Martin Niemiec, James Zhuang, Siddharth Krishnan, Bryan A. Copits, John A. Rogers, Robert W. Gereau, Vijay K. Samineni, Amay J. Bandodkar, Philipp Gutruf

Summary: Neurotransmitters and neuromodulators play a crucial role in neuronal communication, but studying their release dynamics has been challenging due to technical limitations. Researchers have developed an implantable, wireless, and battery-free platform that allows real-time optogenetic stimulation and electrochemical recording of catecholamine dynamics. The platform has a small size and high sensitivity, making it suitable for studying these dynamics in small animal models. In vitro and in vivo experiments have demonstrated the platform's capabilities and its potential applications in studying dopamine concentration changes and opioid effects in freely behaving subjects.

ACS NANO (2023)

Article Biochemistry & Molecular Biology

Mapping the conformational landscape of the stimulatory heterotrimeric G protein

Shuya Kate Huang, Louis-Philippe Picard, Rima S. M. Rahmatullah, Aditya Pandey, Ned Van Eps, Roger K. Sunahara, Oliver P. Ernst, Adnan Sljoka, R. Scott Prosser

Summary: Fluorine nuclear magnetic resonance spectroscopy was used to study the conformational equilibria of the human stimulatory G-protein alpha subunit (G(s)α) in different states. The results showed that the equilibrium is influenced by nucleotide, beta gamma subunit, lipid bilayer, and adenosine A(2A) receptor (A(2A)R). Different helices of G(s)α exhibited dynamic behavior and underwent interactions and transitions associated with G-protein activation. The study revealed a conformational landscape influenced by nucleotides, lipid bilayer, and G-protein-coupled receptor.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2023)

Article Multidisciplinary Sciences

Psychedelics promote neuroplasticity through the activation of intracellular 5-HT2A receptors

Maxemiliano V. Vargas, Lee E. Dunlap, Chunyang Dong, Samuel J. Carter, Robert J. Tombari, Shekib A. Jami, Lindsay P. Cameron, Seona D. Patel, Joseph J. Hennessey, Hannah N. Saeger, John D. McCorvy, John A. Gray, Lin Tian, David E. Olson

Summary: Decreased dendritic spine density in the cortex is a common feature of neuropsychiatric diseases, and psychedelics have been found to promote cortical neuron growth. This study shows that intracellular 5-HT2A receptors mediate the plasticity-promoting effects of psychedelics, providing insight into the mechanisms behind their therapeutic effects. The findings suggest that targeting intracellular 5-HT2A receptors could be a potential therapeutic approach.

SCIENCE (2023)

Editorial Material Biochemical Research Methods

Lighting up action potentials with fast and bright voltage sensors

Alessio Andreoni, Lin Tian

NATURE METHODS (2023)

Article Nanoscience & Nanotechnology

Adeno-associated viral vectors for functional intravenous gene transfer throughout the non-human primate brain

Miguel R. Chuapoco, Nicholas C. Flytzanis, Nick Goeden, J. Christopher Octeau, Kristina M. Roxas, Ken Y. Chan, Jon Scherrer, Janet Winchester, Roy J. Blackburn, Lillian J. Campos, Kwun Nok Mimi Man, Junqing Sun, Xinhong Chen, Arthur Lefevre, Vikram Pal Singh, Cynthia M. Arokiaraj, Timothy F. Shay, Julia Vendemiatti, Min J. Jang, John K. Mich, Yemeserach Bishaw, Bryan B. Gore, Victoria Omstead, Naz Taskin, Natalie Weed, Boaz P. Levi, Jonathan T. Ting, Cory T. Miller, Benjamin E. Deverman, James Pickel, Lin Tian, Andrew S. Fox, Viviana Gradinaru

Summary: Crossing the blood-brain barrier in primates is a major challenge for gene delivery. Researchers have identified an engineered variant, AAV.CAP-Mac, which efficiently delivers genes to the brains of multiple non-human primate species, potentially enabling non-invasive systemic gene transfer.

NATURE NANOTECHNOLOGY (2023)

Meeting Abstract Biochemistry & Molecular Biology

Towards the next generation of genetically encoded fluorescent indicators for neuromodulators

R. R. Dalangin, A. Pal, J. Roshgadol, J. Sun, J. A. Chouinard, S. Kulhavy, Y. Hua, J. R. Wickens, L. Tian

PROTEIN SCIENCE (2023)

Article Biology

Fluorescence Screens for Identifying Central Nervous System-Acting Drug-Biosensor Pairs for Subcellular and Supracellular Pharmacokinetics

Zoe G. Beatty, Anand K. Muthusamy, Elizabeth K. Unger, Dennis A. Dougherty, Lin Tian, Loren L. Looger, Amol V. Shivange, Kallol Bera, Henry A. Lester, Aaron L. Nichols

Summary: Subcellular pharmacokinetic measurements play a crucial role in understanding the mechanisms of CNS-acting drugs. The use of genetically encoded fluorescent biosensors has greatly improved recent investigations, allowing researchers to observe drug behavior at the plasma membrane and in organelles. This study provides protocols for screening and validating hit pairs of drugs and biosensors, as well as optimizing the biosensors for sensitivity and selectivity. The protocols will assist scientists in identifying suitable fluorescent biosensor variants for CNS-acting drugs that currently lack corresponding biosensor partners.

BIO-PROTOCOL (2022)

Meeting Abstract Neurosciences

Using the Genetically Encoded Sensor iSeroSnFR2.0 to Measure Serotonin Release During Fear and Stress Behaviors in Free Moving Mice

Emily Wright, Rochelin Dalangin, Sally Ho, Lin Tian

NEUROPSYCHOPHARMACOLOGY (2022)

Article Neurosciences

Gucy2d selectively marks inhibitory dynorphin neurons in the spinal dorsal horn but is dispensable for pain and itch sensitivity

Elizabeth K. Serafin, Robert Burns, Judy Yoo, Mark L. Baccei

Summary: Gucy2d is selectively expressed in dynorphin-lineage neurons in lamina I-III of the adult mouse spinal cord but not in the brain or DRG. Spinal Gucy2d-expressing neurons are inhibitory neurons that also express the transcription factor Bhlhb5 and the cGMP-dependent phosphodiesterase Pde2a. Gucy2d knockout mice did not exhibit altered responses to itch or pain.

PAIN REPORTS (2021)

No Data Available